New York State Common Retirement Fund’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

New York State Common Retirement Fund’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,422	Closed	-$42K	–	3305
2019 Q1	$42K	Hold	2,422	–	–	﹤0.01%	3087
2018 Q4	$33K	Hold	2,422	–	–	﹤0.01%	3128
2018 Q3	$52K	Hold	2,422	–	–	﹤0.01%	3107
2018 Q2	$104K	Hold	2,422	–	–	﹤0.01%	3079
2018 Q1	$158K	Hold	2,422	–	–	﹤0.01%	2833
2017 Q4	$177K	Hold	2,422	–	–	﹤0.01%	2809
2017 Q3	$222K	Hold	2,422	–	–	﹤0.01%	2720
2017 Q2	$160K	Sell	2,422 -566	-19%	-$70.1K	﹤0.01%	2953
2017 Q1	$648K	Buy	2,988 +11	+0.4%	+$1.57K	﹤0.01%	2258
2016 Q4	$275K	Buy	2,977 +755	+34%	+$85.1K	﹤0.01%	2653
2016 Q3	$300K	Hold	2,222	–	–	﹤0.01%	2584
2016 Q2	$225K	Hold	2,222	–	–	﹤0.01%	2674
2016 Q1	$364K	Hold	2,222	–	–	﹤0.01%	2390
2015 Q4	$728K	Hold	2,222	–	–	﹤0.01%	2136
2015 Q3	$717K	Sell	2,222 -135	-6%	-$59.3K	﹤0.01%	2141
2015 Q2	$939K	Buy	+2,357	New	+$1M	﹤0.01%	2215

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

New York State Common Retirement Fund's LUMO Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 2,422 shares — an estimated $42K sold.

New York State Common Retirement Fund first reported a position in LUMO in Q2 2015 and held it in 16 quarters. The position peaked at $939K in Q2 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

New York State Common Retirement Fund reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 2,422 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $42K.
New York State Common Retirement Fund first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 16 quarters.
New York State Common Retirement Fund's Lumos Pharma, Inc. Common Stock position peaked at $939K in Q2 2015.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.